» Articles » PMID: 39009231

Microbiome's Universe: Impact on Health, Disease and Cancer Treatment

Overview
Journal J Biotechnol
Date 2024 Jul 15
PMID 39009231
Authors
Affiliations
Soon will be listed here.
Abstract

The human microbiome is a diverse ecosystem of microorganisms that reside in the body and influence various aspects of health and well-being. Recent advances in sequencing technology have brought to light microbial communities in organs and tissues that were previously considered sterile. The gut microbiota plays an important role in host physiology, including metabolic functions and immune modulation. Disruptions in the balance of the microbiome, known as dysbiosis, have been linked to diseases such as cancer, inflammatory bowel disease and metabolic disorders. In addition, the administration of antibiotics can lead to dysbiosis by disrupting the structure and function of the gut microbial community. Targeting strategies are the key to rebalancing the microbiome and fighting disease, including cancer, through interventions such as probiotics, fecal microbiota transplantation (FMT), and bacteria-based therapies. Future research must focus on understanding the complex interactions between diet, the microbiome and cancer in order to optimize personalized interventions. Multidisciplinary collaborations are essential if we are going to translate microbiome research into clinical practice. This will revolutionize approaches to cancer prevention and treatment.

Citing Articles

Microbiota and Inflammatory Markers: A Review of Their Interplay, Clinical Implications, and Metabolic Disorders.

Pena-Duran E, Garcia-Galindo J, Lopez-Murillo L, Huerta-Huerta A, Balleza-Alejandri L, Beltran-Ramirez A Int J Mol Sci. 2025; 26(4).

PMID: 40004236 PMC: 11854938. DOI: 10.3390/ijms26041773.


Microbiome Integrity Enhances the Efficacy and Safety of Anticancer Drug.

Mafe A, Busselberg D Biomedicines. 2025; 13(2).

PMID: 40002835 PMC: 11852609. DOI: 10.3390/biomedicines13020422.